Concomitant Targeting of MDM2 and MEK: A New Translatable Combinatorial Strategy?

J Thorac Oncol. 2023 Sep;18(9):1111-1113. doi: 10.1016/j.jtho.2023.06.006.

Authors

Cristina Corno¹, Giovanni Luca Beretta¹, Paola Perego²

Affiliations

¹ Molecular Pharmacology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
² Molecular Pharmacology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: paola.perego@istitutotumori.mi.it.

PMID: 37599041
DOI: 10.1016/j.jtho.2023.06.006

No abstract available

Publication types

Editorial
Comment

MeSH terms

Humans
Lung Neoplasms*
Mitogen-Activated Protein Kinase Kinases
Proto-Oncogene Proteins c-mdm2 / genetics

Substances

Mitogen-Activated Protein Kinase Kinases
MDM2 protein, human
Proto-Oncogene Proteins c-mdm2